Compositions and methods for identifying modulators of transducisomes, a new class of therapeutic targets
View Patent ↗The invention provides cells and methods for identifying modulators of signal transduction, based on transducisome proteins that coordinate and assemble many types of signal transduction proteins. A transducisome is a PDZ domain containing protein that binds at least one signal transduction protein or a PDZ domain containing protein with at least one signal transduction protein bound. Examples of transducisome proteins include INAD, GRIP and other recently identified multi-PDZ domain proteins. Examples of signal transduction proteins include GPCRs, tyrosine kinase receptors, tyrosine phosphatase receptors, ion channels, phospholipases, adenylate cyclases, kinases and G-proteins. Also provided are methods for identifying modulators of signal transduction, proteins (and polynucleotides encoding the same) corresponding to transducisomes, modified transducisomes or defective transducisomes to use in assays of signal transduction, and a screening assay system for detecting protein-protein interactions.
1. A method of identifying a modulator of signal transduction affected by an Inactivation No Afterpotential D (InaD) protein, comprising:
a) contacting a first cell with a test chemical,
wherein said first cell comprises at least one signal transduction protein and a polynucleotide encoding a transducisome protein, and said transducisome protein functionally binds to said signal transduction protein to permit or enhance signal transduction, and wherein the transducisome protein is InaD,
b) activating said signal transduction in said first cell,
c) detecting said signal transduction from said first cell with a signal transduction detection system,
d) contacting a second cell with said test chemical,
wherein said second cell comprises said signal transduction protein and a polynucleotide encoding a defective InaD protein that fails to functionally bind at least one signal transduction protein to permit or enhance signal transduction, and wherein the defective InaD protein comprises an amino acid mutation in a PDZ domain other than an inaD 215 mutation,
e) activating said signal transduction in said second cell,
f) detecting said signal transduction from said second cell with a signal transduction detection system, and
g) comparing said signal transduction from said first cell with signal transduction from said second cell, wherein a difference in detected signal transduction from said first cell and said second cell identifies said test chemical as a modulator of signal transduction affected by InaD.
2. The method of claim 1 , wherein said second cell is the same type of cell as said first cell.
3. The method of claim 1 , wherein the signal transduction protein is a kinase, a phosphatase, a G-protein coupled receptor (GPCR), a tyrosine kinase receptor, a tyrosine phosphatase receptor, an ion channel, a G-protein, a phospholipase or a calcium binding protein.
4. The method of claim 3 , wherein said signal transduction protein is transient receptor potential protein (TRP), protein kinase C, or phospholipase C.
5. The method of claim 1 , wherein the amino acid mutation of said defective InaD is in the first, second, fourth, or fifth PDZ domain.
6. The method of claim 1 , wherein the amino acid mutation of said defective InaD is in the second, fourth, or fifth PDZ domain.
7. The method of claim 1 , wherein the amino acid mutation of said defective InaD is an inaD 2 or an inaD 1 mutation.
8. The method of claim 1 , wherein the amino acid mutation of said defective InaD is in the third PDZ domain and signal transduction is activated with light and detected by detecting an altered latency period.
9. The method of claim 1 , further comprising:
h) contacting a third cell with said test chemical, wherein said third cell comprises said signal transduction protein and a polynucleotide encoding a defective InaD, said defective InaD fails to functionally bind at least one signal transduction protein to permit or enhance signal transduction, and wherein said defective InaD of said third cell comprises a mutation in a PDZ domain, and said defective InaD of said second cell comprises a mutation in a different PDZ domain,
i) activating said signal transduction in said third cell,
j) detecting said signal transduction from said third cell with a signal transduction detection system, and
k) comparing signal transduction from said first cell with signal transduction from said second cell and signal transduction from said third cell, wherein a difference in detected signal transduction between said second cell and said third cell is informative of the signal transduction pathway affected by the modulator.
10. A method of identifying a modulator of signal transduction affected by Inactivation No Afterpotential D (InaD), comprising:
a) contacting a first cell with a test chemical,
wherein said first cell comprises at least one signal transduction protein and a polynucleotide encoding a transducisome protein, and said transducisome protein functionally binds to said signal transduction protein to permit or enhance signal transduction, and wherein said transducisome protein is an InaD polypeptide of SEQ ID NO:1,
b) activating said signal transduction in said first cell,
c) detecting said signal transduction from said first cell with a signal transduction detection system,
d) contacting a second cell with said test chemical,
wherein said second cell comprises said signal transduction protein and a polynucleotide encoding a defective InaD, said defective InaD fails to functionally bind at least one signal transduction protein to permit or enhance signal transduction or said second cells fails to express said InaD polypeptide to permit said InaD polypeptide to functionally bind to at least one signal transduction protein to permit or enhance signal transduction,
e) activating said signal transduction in said second cell,
f) detecting said signal transduction from said second cell with a signal transduction detection system, and
g) comparing said signal transduction from said first cell with signal transduction from said second cell, wherein a difference in detected signal transduction from said first cell and said second cell identifies said test chemical as a modulator of signal transduction affected by InaD.